China Pharma Holdings (CPHI) Change in Inventory (2010 - 2026)
China Pharma Holdings (CPHI) posted Change in Inventory of -$247492.0 for Q1 2026, down 17.54% on a QoQ basis from -$210551.0 in Q4 2025, and down 58.01% year-over-year from -$589457.9 in Q1 2025.
China Pharma Holdings (CPHI) Change in Inventory (2010 - 2026) Analysis & Trends
China Pharma Holdings' Change in Inventory history runs 17 years deep, the most recent figure standing at -$247492.0 for Q1 2026.
- Quarterly Change in Inventory fell 58.01% year-over-year to -$247492.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$680626.0 (up 58.13% YoY) and the FY2025 annual result came in at -$589761.0, up 63.3% from the prior year.
- Change in Inventory was -$247492.0 for Q1 2026 at China Pharma Holdings, down from -$210551.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $552686.0 in Q1 2023 and bottomed at -$582187.0 in Q3 2022.
- A 5-year average of -$183305.1 and a median of -$210551.0 in 2025 frame the typical range for Change in Inventory.
- Peak annual rise in Change in Inventory reached 311.81% in 2022, while the deepest fall reached 533.35% in 2022.
- China Pharma Holdings' Change in Inventory stood at -$192902.0 in 2022, then slumped by 34.09% to -$258659.0 in 2023, then sank by 97.56% to -$510996.0 in 2024, then jumped by 58.8% to -$210551.0 in 2025, then declined by 17.54% to -$247492.0 in 2026.
- Business Quant data shows CPHI's Change in Inventory at -$247492.0 in Q1 2026, -$210551.0 in Q4 2025, and -$57779.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | -247,492.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -247,492.00 |
| Mar 31, 2026 | -247,492.00 |
| Dec 31, 2025 | -210,551.00 |
| Dec 31, 2025 | -210,551.00 |
| Sep 30, 2025 | -57,779.00 |
| Sep 30, 2025 | -57,779.00 |
| Jun 30, 2025 | -164,804.00 |
| Jun 30, 2025 | -164,804.00 |
| Mar 31, 2025 | -156,627.00 |
| Mar 31, 2025 | -156,627.00 |
| Dec 31, 2024 | -510,996.00 |
| Dec 31, 2024 | -510,996.00 |
| Sep 30, 2024 | -376,771.00 |
| Sep 30, 2024 | -376,771.00 |
| Jun 30, 2024 | -581,031.00 |
| Jun 30, 2024 | -581,031.00 |
| Mar 31, 2024 | -138,090.00 |
| Mar 31, 2024 | -138,090.00 |
| Dec 31, 2023 | -258,659.00 |
| Dec 31, 2023 | -258,659.00 |